Third, in the present study, patients with locally advanced HNSCC received induction chemotherapy with TPF followed by concurrent chemoradiotherapy, and we found that patients with RPN2 overexpression had poor PFS and OS. The gene discussed is RPN2; the disease is head and neck squamous cell carcinoma.